866-997-4948(US-Canada Toll Free)

Global Recombinant Human EGF Market Size, Status and Forecast 2020-2026

Published By :

QYResearch

Published Date : Feb 2020

Category :

Healthcare

No. of Pages : 133 Pages

This report focuses on the global Recombinant Human EGF status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Recombinant Human EGF development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study
FUJIFILM Irvine Scientific
PeproTech, Inc
R&D Systems (Bio-Techne)
Miltenyi Biotec
Thermo Fisher Scientific
Abcam PLC
BioLegend Way
STEMCELL Technologies
Eurofins DiscoverX
RayBiotech, Inc
Prospec-Tany
Tonbo Biosciences
EnQuire Bio
ScienCell Research Laboratories
BioVision, Inc
Abm Inc
Cell Guidance Systems
Creative BioMart
Sino Biological
Cell Sciences
Axol Bioscience

Market segment by Type, the product can be split into
98% SDS-PAGE
95%-98% SDS-PAGE
<95% SDS-PAGE
Market segment by Application, split into
Scientific Research
Medical Drug
Others

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Recombinant Human EGF status, future forecast, growth opportunity, key market and key players.
To present the Recombinant Human EGF development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Recombinant Human EGF are as follows:
History Year: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Recombinant Human EGF Revenue
1.4 Market Analysis by Type
1.4.1 Global Recombinant Human EGF Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 98% SDS-PAGE
1.4.3 95%-98% SDS-PAGE
1.4.4 <95% SDS-PAGE
1.5 Market by Application
1.5.1 Global Recombinant Human EGF Market Share by Application: 2020 VS 2026
1.5.2 Scientific Research
1.5.3 Medical Drug
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends by Regions
2.1 Recombinant Human EGF Market Perspective (2015-2026)
2.2 Recombinant Human EGF Growth Trends by Regions
2.2.1 Recombinant Human EGF Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Recombinant Human EGF Historic Market Share by Regions (2015-2020)
2.2.3 Recombinant Human EGF Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porters Five Forces Analysis
2.3.5 Recombinant Human EGF Market Growth Strategy
2.3.6 Primary Interviews with Key Recombinant Human EGF Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Recombinant Human EGF Players by Market Size
3.1.1 Global Top Recombinant Human EGF Players by Revenue (2015-2020)
3.1.2 Global Recombinant Human EGF Revenue Market Share by Players (2015-2020)
3.1.3 Global Recombinant Human EGF Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Recombinant Human EGF Market Concentration Ratio
3.2.1 Global Recombinant Human EGF Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Recombinant Human EGF Revenue in 2019
3.3 Recombinant Human EGF Key Players Head office and Area Served
3.4 Key Players Recombinant Human EGF Product Solution and Service
3.5 Date of Enter into Recombinant Human EGF Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type (2015-2026)
4.1 Global Recombinant Human EGF Historic Market Size by Type (2015-2020)
4.2 Global Recombinant Human EGF Forecasted Market Size by Type (2021-2026)

5 Recombinant Human EGF Breakdown Data by Application (2015-2026)
5.1 Global Recombinant Human EGF Market Size by Application (2015-2020)
5.2 Global Recombinant Human EGF Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Recombinant Human EGF Market Size (2015-2020)
6.2 Recombinant Human EGF Key Players in North America (2019-2020)
6.3 North America Recombinant Human EGF Market Size by Type (2015-2020)
6.4 North America Recombinant Human EGF Market Size by Application (2015-2020)

7 Europe
7.1 Europe Recombinant Human EGF Market Size (2015-2020)
7.2 Recombinant Human EGF Key Players in Europe (2019-2020)
7.3 Europe Recombinant Human EGF Market Size by Type (2015-2020)
7.4 Europe Recombinant Human EGF Market Size by Application (2015-2020)

8 China
8.1 China Recombinant Human EGF Market Size (2015-2020)
8.2 Recombinant Human EGF Key Players in China (2019-2020)
8.3 China Recombinant Human EGF Market Size by Type (2015-2020)
8.4 China Recombinant Human EGF Market Size by Application (2015-2020)

9 Japan
9.1 Japan Recombinant Human EGF Market Size (2015-2020)
9.2 Recombinant Human EGF Key Players in Japan (2019-2020)
9.3 Japan Recombinant Human EGF Market Size by Type (2015-2020)
9.4 Japan Recombinant Human EGF Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Recombinant Human EGF Market Size (2015-2020)
10.2 Recombinant Human EGF Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Recombinant Human EGF Market Size by Type (2015-2020)
10.4 Southeast Asia Recombinant Human EGF Market Size by Application (2015-2020)

11 India
11.1 India Recombinant Human EGF Market Size (2015-2020)
11.2 Recombinant Human EGF Key Players in India (2019-2020)
11.3 India Recombinant Human EGF Market Size by Type (2015-2020)
11.4 India Recombinant Human EGF Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Recombinant Human EGF Market Size (2015-2020)
12.2 Recombinant Human EGF Key Players in Central & South America (2019-2020)
12.3 Central & South America Recombinant Human EGF Market Size by Type (2015-2020)
12.4 Central & South America Recombinant Human EGF Market Size by Application (2015-2020)

13Key Players Profiles
13.1 FUJIFILM Irvine Scientific
13.1.1 FUJIFILM Irvine Scientific Company Details
13.1.2 FUJIFILM Irvine Scientific Business Overview and Its Total Revenue
13.1.3 FUJIFILM Irvine Scientific Recombinant Human EGF Introduction
13.1.4 FUJIFILM Irvine Scientific Revenue in Recombinant Human EGF Business (2015-2020))
13.1.5 FUJIFILM Irvine Scientific Recent Development
13.2 PeproTech, Inc
13.2.1 PeproTech, Inc Company Details
13.2.2 PeproTech, Inc Business Overview and Its Total Revenue
13.2.3 PeproTech, Inc Recombinant Human EGF Introduction
13.2.4 PeproTech, Inc Revenue in Recombinant Human EGF Business (2015-2020)
13.2.5 PeproTech, Inc Recent Development
13.3 R&D Systems (Bio-Techne)
13.3.1 R&D Systems (Bio-Techne) Company Details
13.3.2 R&D Systems (Bio-Techne) Business Overview and Its Total Revenue
13.3.3 R&D Systems (Bio-Techne) Recombinant Human EGF Introduction
13.3.4 R&D Systems (Bio-Techne) Revenue in Recombinant Human EGF Business (2015-2020)
13.3.5 R&D Systems (Bio-Techne) Recent Development
13.4 Miltenyi Biotec
13.4.1 Miltenyi Biotec Company Details
13.4.2 Miltenyi Biotec Business Overview and Its Total Revenue
13.4.3 Miltenyi Biotec Recombinant Human EGF Introduction
13.4.4 Miltenyi Biotec Revenue in Recombinant Human EGF Business (2015-2020)
13.4.5 Miltenyi Biotec Recent Development
13.5 Thermo Fisher Scientific
13.5.1 Thermo Fisher Scientific Company Details
13.5.2 Thermo Fisher Scientific Business Overview and Its Total Revenue
13.5.3 Thermo Fisher Scientific Recombinant Human EGF Introduction
13.5.4 Thermo Fisher Scientific Revenue in Recombinant Human EGF Business (2015-2020)
13.5.5 Thermo Fisher Scientific Recent Development
13.6 Abcam PLC
13.6.1 Abcam PLC Company Details
13.6.2 Abcam PLC Business Overview and Its Total Revenue
13.6.3 Abcam PLC Recombinant Human EGF Introduction
13.6.4 Abcam PLC Revenue in Recombinant Human EGF Business (2015-2020)
13.6.5 Abcam PLC Recent Development
13.7 BioLegend Way
13.7.1 BioLegend Way Company Details
13.7.2 BioLegend Way Business Overview and Its Total Revenue
13.7.3 BioLegend Way Recombinant Human EGF Introduction
13.7.4 BioLegend Way Revenue in Recombinant Human EGF Business (2015-2020)
13.7.5 BioLegend Way Recent Development
13.8 STEMCELL Technologies
13.8.1 STEMCELL Technologies Company Details
13.8.2 STEMCELL Technologies Business Overview and Its Total Revenue
13.8.3 STEMCELL Technologies Recombinant Human EGF Introduction
13.8.4 STEMCELL Technologies Revenue in Recombinant Human EGF Business (2015-2020)
13.8.5 STEMCELL Technologies Recent Development
13.9 Eurofins DiscoverX
13.9.1 Eurofins DiscoverX Company Details
13.9.2 Eurofins DiscoverX Business Overview and Its Total Revenue
13.9.3 Eurofins DiscoverX Recombinant Human EGF Introduction
13.9.4 Eurofins DiscoverX Revenue in Recombinant Human EGF Business (2015-2020)
13.9.5 Eurofins DiscoverX Recent Development
13.10 RayBiotech, Inc
13.10.1 RayBiotech, Inc Company Details
13.10.2 RayBiotech, Inc Business Overview and Its Total Revenue
13.10.3 RayBiotech, Inc Recombinant Human EGF Introduction
13.10.4 RayBiotech, Inc Revenue in Recombinant Human EGF Business (2015-2020)
13.10.5 RayBiotech, Inc Recent Development
13.11 Prospec-Tany
10.11.1 Prospec-Tany Company Details
10.11.2 Prospec-Tany Business Overview and Its Total Revenue
10.11.3 Prospec-Tany Recombinant Human EGF Introduction
10.11.4 Prospec-Tany Revenue in Recombinant Human EGF Business (2015-2020)
10.11.5 Prospec-Tany Recent Development
13.12 Tonbo Biosciences
10.12.1 Tonbo Biosciences Company Details
10.12.2 Tonbo Biosciences Business Overview and Its Total Revenue
10.12.3 Tonbo Biosciences Recombinant Human EGF Introduction
10.12.4 Tonbo Biosciences Revenue in Recombinant Human EGF Business (2015-2020)
10.12.5 Tonbo Biosciences Recent Development
13.13 EnQuire Bio
10.13.1 EnQuire Bio Company Details
10.13.2 EnQuire Bio Business Overview and Its Total Revenue
10.13.3 EnQuire Bio Recombinant Human EGF Introduction
10.13.4 EnQuire Bio Revenue in Recombinant Human EGF Business (2015-2020)
10.13.5 EnQuire Bio Recent Development
13.14 ScienCell Research Laboratories
10.14.1 ScienCell Research Laboratories Company Details
10.14.2 ScienCell Research Laboratories Business Overview and Its Total Revenue
10.14.3 ScienCell Research Laboratories Recombinant Human EGF Introduction
10.14.4 ScienCell Research Laboratories Revenue in Recombinant Human EGF Business (2015-2020)
10.14.5 ScienCell Research Laboratories Recent Development
13.15 BioVision, Inc
10.15.1 BioVision, Inc Company Details
10.15.2 BioVision, Inc Business Overview and Its Total Revenue
10.15.3 BioVision, Inc Recombinant Human EGF Introduction
10.15.4 BioVision, Inc Revenue in Recombinant Human EGF Business (2015-2020)
10.15.5 BioVision, Inc Recent Development
13.16 Abm Inc
10.16.1 Abm Inc Company Details
10.16.2 Abm Inc Business Overview and Its Total Revenue
10.16.3 Abm Inc Recombinant Human EGF Introduction
10.16.4 Abm Inc Revenue in Recombinant Human EGF Business (2015-2020)
10.16.5 Abm Inc Recent Development
13.17 Cell Guidance Systems
10.17.1 Cell Guidance Systems Company Details
10.17.2 Cell Guidance Systems Business Overview and Its Total Revenue
10.17.3 Cell Guidance Systems Recombinant Human EGF Introduction
10.17.4 Cell Guidance Systems Revenue in Recombinant Human EGF Business (2015-2020)
10.17.5 Cell Guidance Systems Recent Development
13.18 Creative BioMart
10.18.1 Creative BioMart Company Details
10.18.2 Creative BioMart Business Overview and Its Total Revenue
10.18.3 Creative BioMart Recombinant Human EGF Introduction
10.18.4 Creative BioMart Revenue in Recombinant Human EGF Business (2015-2020)
10.18.5 Creative BioMart Recent Development
13.19 Sino Biological
10.19.1 Sino Biological Company Details
10.19.2 Sino Biological Business Overview and Its Total Revenue
10.19.3 Sino Biological Recombinant Human EGF Introduction
10.19.4 Sino Biological Revenue in Recombinant Human EGF Business (2015-2020)
10.19.5 Sino Biological Recent Development
13.20 Cell Sciences
10.20.1 Cell Sciences Company Details
10.20.2 Cell Sciences Business Overview and Its Total Revenue
10.20.3 Cell Sciences Recombinant Human EGF Introduction
10.20.4 Cell Sciences Revenue in Recombinant Human EGF Business (2015-2020)
10.20.5 Cell Sciences Recent Development
13.21 Axol Bioscience
10.21.1 Axol Bioscience Company Details
10.21.2 Axol Bioscience Business Overview and Its Total Revenue
10.21.3 Axol Bioscience Recombinant Human EGF Introduction
10.21.4 Axol Bioscience Revenue in Recombinant Human EGF Business (2015-2020)
10.21.5 Axol Bioscience Recent Development

14Analyst's Viewpoints/Conclusions

15Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Table

List of Tables

Table 1. Recombinant Human EGF Key Market Segments
Table 2. Key Players Covered: Ranking by Recombinant Human EGF Revenue
Table 3. Ranking of Global Top Recombinant Human EGF Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Recombinant Human EGF Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of 98% SDS-PAGE
Table 6. Key Players of 95%-98% SDS-PAGE
Table 7. Key Players of <95% SDS-PAGE
Table 8. Global Recombinant Human EGF Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Recombinant Human EGF Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Recombinant Human EGF Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Recombinant Human EGF Market Share by Regions (2015-2020)
Table 12. Global Recombinant Human EGF Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Recombinant Human EGF Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Recombinant Human EGF Market Growth Strategy
Table 18. Main Points Interviewed from Key Recombinant Human EGF Players
Table 19. Global Recombinant Human EGF Revenue by Players (2015-2020) (Million US$)
Table 20. Global Recombinant Human EGF Market Share by Players (2015-2020)
Table 21. Global Top Recombinant Human EGF Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Recombinant Human EGF as of 2019)
Table 22. Global Recombinant Human EGF by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Recombinant Human EGF Product Solution and Service
Table 25. Date of Enter into Recombinant Human EGF Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Recombinant Human EGF Market Size by Type (2015-2020) (Million US$)
Table 28. Global Recombinant Human EGF Market Size Share by Type (2015-2020)
Table 29. Global Recombinant Human EGF Revenue Market Share by Type (2021-2026)
Table 30. Global Recombinant Human EGF Market Size Share by Application (2015-2020)
Table 31. Global Recombinant Human EGF Market Size by Application (2015-2020) (Million US$)
Table 32. Global Recombinant Human EGF Market Size Share by Application (2021-2026)
Table 33. North America Key Players Recombinant Human EGF Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Recombinant Human EGF Market Share (2019-2020)
Table 35. North America Recombinant Human EGF Market Size by Type (2015-2020) (Million US$)
Table 36. North America Recombinant Human EGF Market Share by Type (2015-2020)
Table 37. North America Recombinant Human EGF Market Size by Application (2015-2020) (Million US$)
Table 38. North America Recombinant Human EGF Market Share by Application (2015-2020)
Table 39. Europe Key Players Recombinant Human EGF Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Recombinant Human EGF Market Share (2019-2020)
Table 41. Europe Recombinant Human EGF Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Recombinant Human EGF Market Share by Type (2015-2020)
Table 43. Europe Recombinant Human EGF Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Recombinant Human EGF Market Share by Application (2015-2020)
Table 45. China Key Players Recombinant Human EGF Revenue (2019-2020) (Million US$)
Table 46. China Key Players Recombinant Human EGF Market Share (2019-2020)
Table 47. China Recombinant Human EGF Market Size by Type (2015-2020) (Million US$)
Table 48. China Recombinant Human EGF Market Share by Type (2015-2020)
Table 49. China Recombinant Human EGF Market Size by Application (2015-2020) (Million US$)
Table 50. China Recombinant Human EGF Market Share by Application (2015-2020)
Table 51. Japan Key Players Recombinant Human EGF Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Recombinant Human EGF Market Share (2019-2020)
Table 53. Japan Recombinant Human EGF Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Recombinant Human EGF Market Share by Type (2015-2020)
Table 55. Japan Recombinant Human EGF Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Recombinant Human EGF Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Recombinant Human EGF Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Recombinant Human EGF Market Share (2019-2020)
Table 59. Southeast Asia Recombinant Human EGF Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Recombinant Human EGF Market Share by Type (2015-2020)
Table 61. Southeast Asia Recombinant Human EGF Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Recombinant Human EGF Market Share by Application (2015-2020)
Table 63. India Key Players Recombinant Human EGF Revenue (2019-2020) (Million US$)
Table 64. India Key Players Recombinant Human EGF Market Share (2019-2020)
Table 65. India Recombinant Human EGF Market Size by Type (2015-2020) (Million US$)
Table 66. India Recombinant Human EGF Market Share by Type (2015-2020)
Table 67. India Recombinant Human EGF Market Size by Application (2015-2020) (Million US$)
Table 68. India Recombinant Human EGF Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Recombinant Human EGF Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Recombinant Human EGF Market Share (2019-2020)
Table 71. Central & South America Recombinant Human EGF Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Recombinant Human EGF Market Share by Type (2015-2020)
Table 73. Central & South America Recombinant Human EGF Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Recombinant Human EGF Market Share by Application (2015-2020)
Table 75. FUJIFILM Irvine Scientific Company Details
Table 76. FUJIFILM Irvine Scientific Business Overview
Table 77. FUJIFILM Irvine Scientific Product
Table 78. FUJIFILM Irvine Scientific Revenue in Recombinant Human EGF Business (2015-2020) (Million US$)
Table 79. FUJIFILM Irvine Scientific Recent Development
Table 80. PeproTech, Inc Company Details
Table 81. PeproTech, Inc Business Overview
Table 82. PeproTech, Inc Product
Table 83. PeproTech, Inc Revenue in Recombinant Human EGF Business (2015-2020) (Million US$)
Table 84. PeproTech, Inc Recent Development
Table 85. R&D Systems (Bio-Techne) Company Details
Table 86. R&D Systems (Bio-Techne) Business Overview
Table 87. R&D Systems (Bio-Techne) Product
Table 88. R&D Systems (Bio-Techne) Revenue in Recombinant Human EGF Business (2015-2020) (Million US$)
Table 89. R&D Systems (Bio-Techne) Recent Development
Table 90. Miltenyi Biotec Company Details
Table 91. Miltenyi Biotec Business Overview
Table 92. Miltenyi Biotec Product
Table 93. Miltenyi Biotec Revenue in Recombinant Human EGF Business (2015-2020) (Million US$)
Table 94. Miltenyi Biotec Recent Development
Table 95. Thermo Fisher Scientific Company Details
Table 96. Thermo Fisher Scientific Business Overview
Table 97. Thermo Fisher Scientific Product
Table 98. Thermo Fisher Scientific Revenue in Recombinant Human EGF Business (2015-2020) (Million US$)
Table 99. Thermo Fisher Scientific Recent Development
Table 100. Abcam PLC Company Details
Table 101. Abcam PLC Business Overview
Table 102. Abcam PLC Product
Table 103. Abcam PLC Revenue in Recombinant Human EGF Business (2015-2020) (Million US$)
Table 104. Abcam PLC Recent Development
Table 105. BioLegend Way Company Details
Table 106. BioLegend Way Business Overview
Table 107. BioLegend Way Product
Table 108. BioLegend Way Revenue in Recombinant Human EGF Business (2015-2020) (Million US$)
Table 109. BioLegend Way Recent Development
Table 110. STEMCELL Technologies Business Overview
Table 111. STEMCELL Technologies Product
Table 112. STEMCELL Technologies Company Details
Table 113. STEMCELL Technologies Revenue in Recombinant Human EGF Business (2015-2020) (Million US$)
Table 114. STEMCELL Technologies Recent Development
Table 115. Eurofins DiscoverX Company Details
Table 116. Eurofins DiscoverX Business Overview
Table 117. Eurofins DiscoverX Product
Table 118. Eurofins DiscoverX Revenue in Recombinant Human EGF Business (2015-2020) (Million US$)
Table 119. Eurofins DiscoverX Recent Development
Table 120. RayBiotech, Inc Company Details
Table 121. RayBiotech, Inc Business Overview
Table 122. RayBiotech, Inc Product
Table 123. RayBiotech, Inc Revenue in Recombinant Human EGF Business (2015-2020) (Million US$)
Table 124. RayBiotech, Inc Recent Development
Table 125. Prospec-Tany Company Details
Table 126. Prospec-Tany Business Overview
Table 127. Prospec-Tany Product
Table 128. Prospec-Tany Revenue in Recombinant Human EGF Business (2015-2020) (Million US$)
Table 129. Prospec-Tany Recent Development
Table 130. Tonbo Biosciences Company Details
Table 131. Tonbo Biosciences Business Overview
Table 132. Tonbo Biosciences Product
Table 133. Tonbo Biosciences Revenue in Recombinant Human EGF Business (2015-2020) (Million US$)
Table 134. Tonbo Biosciences Recent Development
Table 135. EnQuire Bio Company Details
Table 136. EnQuire Bio Business Overview
Table 137. EnQuire Bio Product
Table 138. EnQuire Bio Revenue in Recombinant Human EGF Business (2015-2020) (Million US$)
Table 139. EnQuire Bio Recent Development
Table 140. ScienCell Research Laboratories Company Details
Table 141. ScienCell Research Laboratories Business Overview
Table 142. ScienCell Research Laboratories Product
Table 143. ScienCell Research Laboratories Revenue in Recombinant Human EGF Business (2015-2020) (Million US$)
Table 144. ScienCell Research Laboratories Recent Development
Table 145. BioVision, Inc Company Details
Table 146. BioVision, Inc Business Overview
Table 147. BioVision, Inc Product
Table 148. BioVision, Inc Revenue in Recombinant Human EGF Business (2015-2020) (Million US$)
Table 149. BioVision, Inc Recent Development
Table 150. Abm Inc Company Details
Table 151. Abm Inc Business Overview
Table 152. Abm Inc Product
Table 153. Abm Inc Revenue in Recombinant Human EGF Business (2015-2020) (Million US$)
Table 154. Abm Inc Recent Development
Table 155. Cell Guidance Systems Company Details
Table 156. Cell Guidance Systems Business Overview
Table 157. Cell Guidance Systems Product
Table 158. Cell Guidance Systems Revenue in Recombinant Human EGF Business (2015-2020) (Million US$)
Table 159. Cell Guidance Systems Recent Development
Table 160. Creative BioMart Company Details
Table 161. Creative BioMart Business Overview
Table 162. Creative BioMart Product
Table 163. Creative BioMart Revenue in Recombinant Human EGF Business (2015-2020) (Million US$)
Table 164. Creative BioMart Recent Development
Table 165. Sino Biological Company Details
Table 166. Sino Biological Business Overview
Table 167. Sino Biological Product
Table 168. Sino Biological Revenue in Recombinant Human EGF Business (2015-2020) (Million US$)
Table 169. Sino Biological Recent Development
Table 170. Cell Sciences Company Details
Table 171. Cell Sciences Business Overview
Table 172. Cell Sciences Product
Table 173. Cell Sciences Revenue in Recombinant Human EGF Business (2015-2020) (Million US$)
Table 174. Cell Sciences Recent Development
Table 175. Axol Bioscience Company Details
Table 176. Axol Bioscience Business Overview
Table 177. Axol Bioscience Product
Table 178. Axol Bioscience Revenue in Recombinant Human EGF Business (2015-2020) (Million US$)
Table 179. Axol Bioscience Recent Development
Table 180. Research Programs/Design for This Report
Table 181. Key Data Information from Secondary Sources
Table 182. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Recombinant Human EGF Market Share by Type: 2020 VS 2026
Figure 2. 98% SDS-PAGE Features
Figure 3. 95%-98% SDS-PAGE Features
Figure 4. <95% SDS-PAGE Features
Figure 5. Global Recombinant Human EGF Market Share by Application: 2020 VS 2026
Figure 6. Scientific Research Case Studies
Figure 7. Medical Drug Case Studies
Figure 8. Others Case Studies
Figure 9. Recombinant Human EGF Report Years Considered
Figure 10. Global Recombinant Human EGF Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Recombinant Human EGF Market Share by Regions: 2020 VS 2026
Figure 12. Global Recombinant Human EGF Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Recombinant Human EGF Market Share by Players in 2019
Figure 15. Global Top Recombinant Human EGF Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Recombinant Human EGF as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Recombinant Human EGF Revenue in 2019
Figure 17. North America Recombinant Human EGF Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Recombinant Human EGF Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Recombinant Human EGF Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Recombinant Human EGF Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Recombinant Human EGF Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Recombinant Human EGF Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Recombinant Human EGF Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. FUJIFILM Irvine Scientific Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. FUJIFILM Irvine Scientific Revenue Growth Rate in Recombinant Human EGF Business (2015-2020)
Figure 26. PeproTech, Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. PeproTech, Inc Revenue Growth Rate in Recombinant Human EGF Business (2015-2020)
Figure 28. R&D Systems (Bio-Techne) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. R&D Systems (Bio-Techne) Revenue Growth Rate in Recombinant Human EGF Business (2015-2020)
Figure 30. Miltenyi Biotec Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Miltenyi Biotec Revenue Growth Rate in Recombinant Human EGF Business (2015-2020)
Figure 32. Thermo Fisher Scientific Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Thermo Fisher Scientific Revenue Growth Rate in Recombinant Human EGF Business (2015-2020)
Figure 34. Abcam PLC Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Abcam PLC Revenue Growth Rate in Recombinant Human EGF Business (2015-2020)
Figure 36. BioLegend Way Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. BioLegend Way Revenue Growth Rate in Recombinant Human EGF Business (2015-2020)
Figure 38. STEMCELL Technologies Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. STEMCELL Technologies Revenue Growth Rate in Recombinant Human EGF Business (2015-2020)
Figure 40. Eurofins DiscoverX Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Eurofins DiscoverX Revenue Growth Rate in Recombinant Human EGF Business (2015-2020)
Figure 42. RayBiotech, Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. RayBiotech, Inc Revenue Growth Rate in Recombinant Human EGF Business (2015-2020)
Figure 44. Prospec-Tany Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. Prospec-Tany Revenue Growth Rate in Recombinant Human EGF Business (2015-2020)
Figure 46. Tonbo Biosciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. Tonbo Biosciences Revenue Growth Rate in Recombinant Human EGF Business (2015-2020)
Figure 48. EnQuire Bio Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. EnQuire Bio Revenue Growth Rate in Recombinant Human EGF Business (2015-2020)
Figure 50. ScienCell Research Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. ScienCell Research Laboratories Revenue Growth Rate in Recombinant Human EGF Business (2015-2020)
Figure 52. BioVision, Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. BioVision, Inc Revenue Growth Rate in Recombinant Human EGF Business (2015-2020)
Figure 54. Abm Inc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Abm Inc Revenue Growth Rate in Recombinant Human EGF Business (2015-2020)
Figure 56. Cell Guidance Systems Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Cell Guidance Systems Revenue Growth Rate in Recombinant Human EGF Business (2015-2020)
Figure 58. Creative BioMart Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Creative BioMart Revenue Growth Rate in Recombinant Human EGF Business (2015-2020)
Figure 60. Sino Biological Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Sino Biological Revenue Growth Rate in Recombinant Human EGF Business (2015-2020)
Figure 62. Cell Sciences Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. Cell Sciences Revenue Growth Rate in Recombinant Human EGF Business (2015-2020)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *